Avanos Medical, Inc.
AVNS
$11.16
-$0.20-1.76%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 175.00M | 167.50M | 179.60M | 170.40M | 171.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 175.00M | 167.50M | 179.60M | 170.40M | 171.70M |
| Cost of Revenue | 82.90M | 77.70M | 81.60M | 77.50M | 76.10M |
| Gross Profit | 92.10M | 89.80M | 98.00M | 92.90M | 95.60M |
| SG&A Expenses | 83.50M | 75.70M | 96.00M | 69.80M | 80.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 300.00K | -1.60M | 1.30M | -600.00K | 2.10M |
| Total Operating Expenses | 172.50M | 157.20M | 170.80M | 153.90M | 165.40M |
| Operating Income | 2.50M | 10.30M | 8.80M | 16.50M | 6.30M |
| Income Before Tax | -75.90M | 9.70M | -420.50M | 9.50M | 6.20M |
| Income Tax Expenses | 900.00K | 3.10M | -23.50M | 3.60M | 1.90M |
| Earnings from Continuing Operations | -76.80M | 6.60M | -397.00M | 5.90M | 4.30M |
| Earnings from Discontinued Operations | -- | -- | -300.00K | -1.60M | -2.50M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -76.80M | 6.60M | -397.30M | 4.30M | 1.80M |
| EBIT | 2.50M | 10.30M | 8.80M | 16.50M | 6.30M |
| EBITDA | 12.50M | 19.90M | 19.90M | 28.20M | 17.60M |
| EPS Basic | -1.66 | 0.14 | -8.64 | 0.09 | 0.04 |
| Normalized Basic EPS | 0.01 | 0.13 | 0.09 | 0.19 | 0.08 |
| EPS Diluted | -1.66 | 0.14 | -8.64 | 0.09 | 0.04 |
| Normalized Diluted EPS | 0.01 | 0.13 | 0.09 | 0.19 | 0.08 |
| Average Basic Shares Outstanding | 46.30M | 46.10M | 46.00M | 46.00M | 45.90M |
| Average Diluted Shares Outstanding | 46.30M | 46.80M | 46.00M | 46.60M | 46.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |